ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466,869 | -12.8% | 17,414 | 0.0% | 0.35% | -13.0% |
| Q2 2023 | $535,306 | -22.2% | 17,414 | 0.0% | 0.40% | -32.2% |
| Q4 2022 | $688,201 | -1.7% | 17,414 | 0.0% | 0.59% | -10.3% |
| Q3 2022 | $700,000 | -4.4% | 17,414 | 0.0% | 0.66% | -1.5% |
| Q2 2022 | $732,000 | +8.0% | 17,414 | 0.0% | 0.67% | +19.3% |
| Q1 2022 | $678,000 | +42.4% | 17,414 | +45.8% | 0.56% | +48.1% |
| Q4 2021 | $476,000 | – | 11,942 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |